The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
Young UC alums, students and faculty from eight campuses and two national labs made the Forbes 30 Under 30 list across a slew ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
THIRUVANANTHAPURAM: Two new centres of excellence, focusing on specific areas of advanced research and training, have come up ...
Asian nations including India must take steps to empower workforces to take advantage of talent shortages in US firms The new ...
Audio storytelling is emerging as a powerful tool for testing and developing film and television content, with Latino-focused ...
Karoon’s balance sheet remains sound following the Who Dat acquisition. From a net cash position of USD 152 million or just over AUD 0.40 per share as of the end of September 2023, the balance sheet ...
Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...
Energy demands from big tech, including for AI, has elected officials giving an old power source a second look.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback